Literature DB >> 30560889

Pre-emptive medicine for hypertension and its prospects.

Hiroshi Itoh1, Kaori Hayashi2, Kazutoshi Miyashita2.   

Abstract

Pre-emptive medicine is a novel medical concept proposed in Japan that aims to precisely predict the onset and progression of diseases and to provide therapeutic interventions during early stages, before symptoms appear. The concept of pre-emptive medicine considers the time-course of a disease in each individual and seeks medical interventions to prevent disease progression. Suitable and promising targets for pre-emptive medicine are non-communicable diseases, including hypertension. Recent advances in genomic analysis, information technology, and artificial intelligence should make this medical concept feasible in the near future. In this review, we focused on pre-emptive medicine for hypertension, referring to concrete plans for the future direction of this research. The ultimate goal of pre-emptive medicine is to completely prevent the onset and progression of hypertension by precisely predicting the elevation of blood pressure and performing interventions to avoid it. The diagnostic processes of hypertension, from the standpoint of pre-emptive medicine, should include the detection of abnormal blood pressure regulation as the earliest manifestation of the disease, the depiction of the present status of hypertension in an individual ("nowcasting"), and a prediction of the future trajectory of the disease ("forecasting"). Novel therapeutic strategies for hypertension, from the standpoint of pre-emptive medicine, should aim for the regression of hypertension through early treatments and the remission of hypertension through intermittent intensive therapies. An efficient modification of lifestyle and therapies, according to the progression of hypertension, should be required. If pre-emptive medicine for hypertension becomes established, it would greatly contribute to the extension of a healthy lifespan, which cannot yet be satisfactorily achieved.

Entities:  

Keywords:  Forecasting of hypertension; Hypertension; Hypertension Mosaicogram; Nowcasting of hypertension; Pre-emptive medicine

Year:  2018        PMID: 30560889     DOI: 10.1038/s41440-018-0177-3

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  4 in total

Review 1.  Gene-environment interactions related to maternal exposure to environmental and lifestyle-related chemicals during pregnancy and the resulting adverse fetal growth: a review.

Authors:  Sumitaka Kobayashi; Fumihiro Sata; Reiko Kishi
Journal:  Environ Health Prev Med       Date:  2022       Impact factor: 4.395

Review 2.  Low birth weight trends: possible impacts on the prevalences of hypertension and chronic kidney disease.

Authors:  Takeshi Kanda; Ayano Murai-Takeda; Hiroshi Kawabe; Hiroshi Itoh
Journal:  Hypertens Res       Date:  2020-05-11       Impact factor: 3.872

3.  The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future.

Authors:  Stefano Omboni; Raj S Padwal; Tourkiah Alessa; Béla Benczúr; Beverly B Green; Ilona Hubbard; Kazuomi Kario; Nadia A Khan; Alexandra Konradi; Alexander G Logan; Yuan Lu; Maurice Mars; Richard J McManus; Sarah Melville; Claas L Neumann; Gianfranco Parati; Nicolas F Renna; Philippe Ryvlin; Hugo Saner; Aletta E Schutte; Jiguang Wang
Journal:  Connect Health       Date:  2022-01-04

4.  A "Third Wheel" Effect in Health Decision Making Involving Artificial Entities: A Psychological Perspective.

Authors:  Stefano Triberti; Ilaria Durosini; Gabriella Pravettoni
Journal:  Front Public Health       Date:  2020-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.